National Health Investors Inc NHI
1,002 filings, 6 in the last 30 days
SEC filing indexWhat the 8-Ks said
2 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Apr 23, 2026 CEO, CFO, COO or CAOCFO change “(the “Company”) of his intention to retire from his position as Executive Vice President of Finance, Chief Financial Officer and Treasurer, effective as of July 1, 2026.” 8-K item 5.02 · all documents
- Feb 23, 2026 CEO, CFO, COO or CAOCEO change “Eric Mendelsohn, the President and Chief Executive Officer and a director of the Company, provided notice of his resignation as a director, effective immediately.” 8-K item 5.02 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
Facts worth reading in the filing: 1 found
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-K“In 2022, we began recognizing rental income from Bickford’s leases using the cash basis of accounting for revenue recognition based upon information we obtained from Bickford regarding its financial condition that raised substantial doubt about its ability to continue as a going concern.”
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 60 events
- Nov 13, 2026 8-K Director or officer change8-K item 5.02
- Nov 9, 2026 8-K Quarterly results8-K item 2.02
- Nov 9, 2026 8-K Regulation FD disclosure8-K item 7.01
- Nov 9, 2026 8-K Regulation FD disclosure8-K item 7.01
- Nov 9, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Aug 27, 2026 8-K Director or officer change8-K item 5.02
- Aug 17, 2026 Planned sale Spaid John L (Officer) gave notice of a planned sale of 33,124 shares worth about $2.4MForm 144, approximate sale date Aug 17, 2026
- Aug 10, 2026 8-K Quarterly results8-K item 2.02
- Aug 10, 2026 8-K Regulation FD disclosure8-K item 7.01
- Aug 10, 2026 8-K Regulation FD disclosure8-K item 7.01
- Aug 10, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 27, 2026 8-K Director or officer change8-K item 5.02
- Jul 1, 2026 8-K Director or officer change8-K item 5.02
- Jul 1, 2026 8-K Material agreement ended, Acquisition or sale of assets completed8-K items 1.02, 2.01
- Jun 15, 2026 Buy MCCABE ROBERT A JR (Director) bought $64Kopen-market purchase on Jun 15, 2026
- Jun 5, 2026 Buy Mendelsohn D. Eric (CEO and President) bought $103Kopen-market purchase on Jun 5, 2026
- Jun 1, 2026 8-K Other events8-K item 8.01
- May 29, 2026 8-K Shareholder vote results8-K item 5.07
- May 4, 2026 8-K Quarterly results8-K item 2.02
- May 4, 2026 8-K Regulation FD disclosure8-K item 7.01
- May 4, 2026 8-K Regulation FD disclosure8-K item 7.01
- May 4, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 23, 2026 Officer CFO change(the “Company”) of his intention to retire from his position as Executive Vice President of Finance, Chief Financial Officer and Treasurer, effective as of July 1, 2026.
- Apr 22, 2026 8-K Material agreement signed, Material agreement ended, Regulation FD disclosure (amended)8-K items 1.01, 1.02, 7.01
- Apr 21, 2026 8-K Material agreement signed, Material agreement ended, Regulation FD disclosure8-K items 1.01, 1.02, 7.01
- Mar 16, 2026 Offering At-the-market program: up to $500M of common stock424B5 · … aggregate gross sales price of up to $500 million may be offered and sold from time to time through the Sales Agents and the Forward Sellers or directly by us to the Sales Agents as principals.
- Mar 16, 2026 Offering Shelf registration: shares and other securities, amount not fixedS-3ASR · Units National Health Investors, Inc. (“NHI”) may offer and sell from time to time, in one or more offerings, in one or more classes or series: • shares of common stock; shares of preferred stock; debt securities; warrants; and/or units consisting of combinations of any of the foregoing.
- Mar 16, 2026 8-K Other events8-K item 8.01
- Feb 26, 2026 8-K Quarterly results8-K item 2.02
- Feb 26, 2026 8-K Regulation FD disclosure8-K item 7.01
- Feb 26, 2026 8-K Regulation FD disclosure8-K item 7.01
- Feb 26, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 23, 2026 Officer CEO changeEric Mendelsohn, the President and Chief Executive Officer and a director of the Company, provided notice of his resignation as a director, effective immediately.
- Dec 19, 2025 8-K Director or officer change8-K item 5.02
- Nov 6, 2025 8-K Quarterly results8-K item 2.02
- Nov 6, 2025 8-K Regulation FD disclosure8-K item 7.01
- Nov 6, 2025 8-K Regulation FD disclosure8-K item 7.01
- Nov 6, 2025 8-K Director or officer change8-K item 5.02
- Nov 6, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Sep 26, 2025 8-K Material agreement signed, New debt or obligation, Other events8-K items 1.01, 2.03, 8.01
- Sep 8, 2025 8-K Other events8-K item 8.01
- Aug 6, 2025 8-K Quarterly results8-K item 2.02
- Aug 6, 2025 8-K Regulation FD disclosure8-K item 7.01
- Aug 6, 2025 8-K Regulation FD disclosure8-K item 7.01
- Aug 6, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jun 2, 2025 8-K Regulation FD disclosure8-K item 7.01
- May 28, 2025 8-K Shareholder vote results8-K item 5.07
- May 5, 2025 8-K Quarterly results8-K item 2.02
- May 5, 2025 8-K Regulation FD disclosure8-K item 7.01
- May 5, 2025 8-K Regulation FD disclosure8-K item 7.01
- May 5, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Mar 27, 2025 8-K Director or officer change8-K item 5.02
- Feb 25, 2025 8-K Quarterly results8-K item 2.02
- Feb 25, 2025 8-K Regulation FD disclosure8-K item 7.01
- Feb 25, 2025 8-K Regulation FD disclosure8-K item 7.01
- Feb 25, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Feb 10, 2025 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Jan 8, 2025 8-K Director or officer change (amended)8-K item 5.02
- Jan 8, 2025 8-K Regulation FD disclosure8-K item 7.01
- Dec 2, 2024 8-K Director or officer change8-K item 5.02
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 13, 2026 | 8-K | Director or officer change |
| Nov 9, 2026 | 8-K | Regulation FD disclosure |
| Nov 9, 2026 | 8-K | Regulation FD disclosure |
| Nov 9, 2026 | 8-K | Quarterly results |
| Nov 9, 2026 | 10-Q | Quarterly report |
| Oct 30, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 27, 2026 | 8-K | Director or officer change |
| Aug 17, 2026 | 144 | Notice of planned insider sale |
| Aug 10, 2026 | 8-K | Regulation FD disclosure |
| Aug 10, 2026 | 8-K | Regulation FD disclosure |
| Aug 10, 2026 | 8-K | Quarterly results |
| Aug 10, 2026 | 10-Q | Quarterly report |
| Jul 30, 2026 | 4 | Insider trade |
| Jul 30, 2026 | 3 | New insider |
| Jul 27, 2026 | 8-K | Director or officer change |
| Jul 8, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jul 2, 2026 | 3 | New insider |
| Jul 1, 2026 | 8-K | Material agreement ended, Acquisition or sale of assets completed |
| Jul 1, 2026 | 8-K | Director or officer change |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 8-K | Other events |
| May 29, 2026 | 8-K | Shareholder vote results |
| May 7, 2026 | 4 | Insider trade |
| May 7, 2026 | 4 | Insider trade |
| May 7, 2026 | 4 | Insider trade |
| May 4, 2026 | 8-K | Regulation FD disclosure |
| May 4, 2026 | 8-K | Regulation FD disclosure |
| May 4, 2026 | 8-K | Quarterly results |
| May 4, 2026 | 10-Q | Quarterly report |
| Apr 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 29, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 23, 2026 | 8-K | Director or officer change |
| Apr 22, 2026 | 8-K/A | Material agreement signed, Material agreement ended, Regulation FD disclosure |
| Apr 21, 2026 | 8-K | Material agreement signed, Material agreement ended, Regulation FD disclosure |
| Apr 3, 2026 | ARS | Annual report to shareholders |
| Apr 3, 2026 | DEFA14A | Extra proxy material |
| Apr 3, 2026 | DEF 14A | Proxy statement |
| Mar 30, 2026 | 3/A | New insider (amended) |
| Mar 30, 2026 | 4/A | Insider trade (amended) |
| Mar 30, 2026 | 4/A | Insider trade (amended) |
| Mar 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 16, 2026 | 8-K | Other events |
| Mar 16, 2026 | 424B5 | Prospectus |
| Mar 16, 2026 | S-3ASR | Shelf registration |
| Mar 5, 2026 | 4 | Insider trade |
| Mar 5, 2026 | 4 | Insider trade |
| Mar 5, 2026 | 4 | Insider trade |
| Mar 5, 2026 | 4 | Insider trade |
| Mar 5, 2026 | 4 | Insider trade |
| Mar 5, 2026 | 4 | Insider trade |
| Mar 5, 2026 | 4 | Insider trade |
| Mar 5, 2026 | 4 | Insider trade |
| Mar 5, 2026 | 4 | Insider trade |
| Mar 5, 2026 | 4 | Insider trade |
| Mar 5, 2026 | 4 | Insider trade |
| Mar 4, 2026 | 3 | New insider |
| Feb 27, 2026 | 3 | New insider |
| Feb 26, 2026 | 8-K | Regulation FD disclosure |
| Feb 26, 2026 | 8-K | Regulation FD disclosure |
| Feb 26, 2026 | 8-K | Quarterly results |
| Feb 26, 2026 | 10-K | Annual report |
| Feb 25, 2026 | 4 | Insider trade |
| Feb 25, 2026 | 4 | Insider trade |
| Feb 25, 2026 | 4 | Insider trade |
| Feb 25, 2026 | 4 | Insider trade |
| Feb 23, 2026 | 4 | Insider trade |
| Feb 23, 2026 | 8-K | Director or officer change |
| Feb 19, 2026 | 4 | Insider trade |
| Feb 19, 2026 | 4 | Insider trade |
| Feb 17, 2026 | 4 | Insider trade |
| Feb 13, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 9, 2026 | 4 | Insider trade |
| Feb 3, 2026 | 4 | Insider trade |
| Feb 3, 2026 | 4 | Insider trade |
| Jan 29, 2026 | 4 | Insider trade |
| Jan 20, 2026 | 4 | Insider trade |
| Jan 16, 2026 | 4 | Insider trade |
| Jan 16, 2026 | 4 | Insider trade |
| Dec 19, 2025 | 8-K | Director or officer change |
| Dec 11, 2025 | 4 | Insider trade |
| Nov 24, 2025 | 4 | Insider trade |
| Nov 6, 2025 | 8-K | Director or officer change |
| Nov 6, 2025 | 8-K | Regulation FD disclosure |
| Nov 6, 2025 | 8-K | Regulation FD disclosure |
| Nov 6, 2025 | 8-K | Quarterly results |
| Nov 6, 2025 | 10-Q | Quarterly report |
| Sep 26, 2025 | 8-K | Material agreement signed, New debt or obligation, Other events |
| Sep 25, 2025 | 4 | Insider trade |
| Sep 23, 2025 | 424B5 | Prospectus |
| Sep 22, 2025 | FWP | Offering terms |
| Sep 22, 2025 | 424B5 | Prospectus |
| Sep 22, 2025 | POSASR | |
| Sep 8, 2025 | 8-K | Other events |
| Aug 6, 2025 | 8-K | Regulation FD disclosure |
| Aug 6, 2025 | 8-K | Regulation FD disclosure |
| Aug 6, 2025 | 8-K | Quarterly results |
| Aug 6, 2025 | 10-Q | Quarterly report |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/NHI/export.csv") into a cell.